Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins

A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus

(2017) Rutger M. Schepp et al.   JOURNAL OF VIROLOGICAL METHODS

Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein

(2017) A. Leemans et al.   JOURNAL OF VIROLOGY

In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants

(2017) Elisabeth A. van Erp et al.   JOURNAL OF VIROLOGY

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

(2017) Daiyin Tian et al.   Nature Communications

Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV

(2016) Ivy Widjaja et al.   JOURNAL OF VIROLOGY

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein

(2016) Jarrod J. Mousa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccines against respiratory syncytial virus: The time has finally come

(2016) Barney S. Graham   VACCINE

Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus

(2016) Sarah V. Maifeld et al.   PLoS One

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

(2015) Joan O. Ngwuta et al.   Science Translational Medicine

Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein

(2015) Jason S McLellan   Current Opinion in Virology

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

(2015) Morgan S. A. Gilman et al.   PLoS Pathogens

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants

(2015) Alienke J. Wijmenga-Monsuur et al.   PLoS One

Respiratory syncytial virus protein structure, function and implications for subunit vaccine development

(2014) Michael McCarthy et al.   Future Virology

Translational sciences approach to RSV vaccine development

(2013) Vanessa Kurzweil et al.   Expert Review of Vaccines

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis

(2013) Christopher S. Ambrose et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

(2013) J. S. McLellan et al.   SCIENCE

Strategic priorities for respiratory syncytial virus (RSV) vaccine development

(2013) L.J. Anderson et al.   VACCINE

Development of a Bead-Based Multiplex Immunoassay for Simultaneous Quantitative Detection of IgG Serum Antibodies against Measles, Mumps, Rubella, and Varicella-Zoster Virus

(2012) Gaby P. Smits et al.   Clinical and Vaccine Immunology

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

(2011) J. S. McLellan et al.   JOURNAL OF VIROLOGY

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins

(2010) Lotte H. Hendrikx et al.   VACCINE

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus

(2008) Pieter G.M. van Gageldonk et al.   JOURNAL OF IMMUNOLOGICAL METHODS